ADIPOQ and coronary artery disorder: In the clinical practice, adiponectin levels also correlate positively with coronary heart disease recurrence and all-cause and cardiovascular mortality among patients with established cardiovascular disease [55] as well as in elevated circulating total adiponectin levels, which were associated with lower 10-year CVD risk in adults without previous CVD, independently of other established CVD risk factors.